Dominik Hochli, MD

Co-owner Abinode AG

📍 Netherlands🔄 Updated September 2026💼 1 investments📅 2 years investing🗓 Last invested Jan 2024
VC🌍 Netherlands
1
Total investments
1
Early stage
0
Mid stage
0
Late stage
2y
Years active

Portfolio

1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Angel Investor
Jan 2024
With Adon Health, we pursue the vision of transforming the European healthcare landscape by enabling innovative, data-driven and personalised treatment paths for hormonal disorders in men under medical supervision. Our current objective is simplifying access to and treatment of testosterone deficiencies, we therefore offer: 1. At-home laboratory test kits for testosterone level measurement 2. Telemedical consultation with independent specialists 3. Treatment and post-treatment care and patient support We believe that every man has the right to a fulfilling and healthy life. Thats why, with our cutting-edge technology and network of leading experts, we are creating a future where treating hormonal imbalances is no longer a taboo subject, but an integral part of mens health.
Experience · 5 entries
All (5)
Investments (1)
2024
Founding Member
Apr 2024
Life Science Cares Switzerland brings together the Life Science Community and NPOs to build bridges.
Angel Investor
Jan 2024
With Adon Health, we pursue the vision of transforming the European healthcare landscape by enabling innovative, data-driven and personalised treatment paths for hormonal disorders in men under medical supervision. Our current objective is simplifying access to and treatment of testosterone deficiencies, we therefore offer: 1. At-home laboratory test kits for testosterone level measurement 2. Telemedical consultation with independent specialists 3. Treatment and post-treatment care and patient support We believe that every man has the right to a fulfilling and healthy life. Thats why, with our cutting-edge technology and network of leading experts, we are creating a future where treating hormonal imbalances is no longer a taboo subject, but an integral part of mens health.
2021
Managing Director
May 2021
Catapult Therapeutics is a privately held Dutch biotech company developing CAP-100 – an innovative first-in-class humanized anti-CCR7 antibody.
Member of the Board of Directors
Apr 2021
Molecular Partners AG is a clinical-stage biotech company pioneering the design and development of DARPin therapeutics, a new class of custom-built drugs for medical challenges other modalities cannot readily address. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. Molecular Partners leverages the advantages of DARPins to provide unique solutions to patients through its proprietary programs as well as through partnerships with leading pharmaceutical companies. Molecular Partners was founded in 2004 and has offices in both Zürich, Switzerland and Concord, MA, USA.
2008
General Manager Switzerland
Dec 2008
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritional and branded generic medicines. Our 122,000 colleagues serve people in more than 160 countries. Connect with us at www.abbott.com, on Facebook at www.facebook.com/Abbott and www.facebook.com/AbbottCareers, on Instagram @AbbottGlobal, and on X @AbbottNews. We invite you to explore opportunities at Abbott, to see if your talents and career aspirations may fit with our openings. An equal opportunity employer, Abbott welcomes and encourages diversity in our workforce. Terms of Use: https://www.abbott.com/social-media-terms-of-use.html Privacy Policy: https://abbo.tt/privacy